Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients

Diabetologia

Volumn 40, Issue 12, 1997, Pages 1439-1448

  Henriksen, J E ^a   Alford, F ^b   Ward, G M ^b   Beck Nielsen, H ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

Glucose intolerance; Insulin resistance; Insulin secretion; Minimal model analysis; Relatives of NIDDM patients; Steroids

Indexed keywords

C PEPTIDE; DEXAMETHASONE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DETERIORATION; FAMILY HISTORY; FEMALE; GENETIC PREDISPOSITION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; INTRAVENOUS DRUG ADMINISTRATION; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RELATIVE;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; CHOLESTEROL, HDL; DEXAMETHASONE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; RISK FACTORS;

EID: 0031437952     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050847     Document Type: Article

References (45)

1. Beck Nielsen H, Groop LC (1994) Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non- insulin-dependent diabetes mellitus. J Clin Invest 94: 1714-1721
2. Porte DJ (1991) Banting lecture 1990. Beta-cells in type II diabetes mellitus. Diabetes 40: 166-180
3. Kobberling J, Tillil H (1982) Empirical risk figures for first-degree relatives of non-insulin dependent diabetics. In: Kobberling J, Tattersall R (eds) The genetics of diabetes mellitus. Academic Press, London New York, pp 202-209
4. Eriksson J, Franssila Kallunki A, Ekstrand A et al. (1989) Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337-343
5. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR (1992) Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340: 925-929
6. Vaag A, Henriksen JE, Beck Nielsen H (1992) Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 89: 782-788
7. Henriksen JE, Alford F, Handberg A et al. (1994) Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism. J Clin Invest 94: 1196-1204
8. Lillioja S, Mott DM, Spraul M et al. (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin- dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329: 1988-1992
9. Vaag A. Henriksen JE, Madsbad S, Holm N, Beck-Nielsen H (1995) Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. J Clin Invest 95: 690-698
10. Pimenta W, Korytkowski M, Mitrakou A et al. (1995) Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM: evidence from studies in normal glucose-tolerant individuals with a first degree NIDDM relative. J Am Med Assoc 273: 1855-1861
11. DeFronzo RA (1988) Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NID-DM. Diabetes 37: 667-687
12. Yki Jarvinen H (1994) Pathogenesis of non-insulin-dependent diabetes mellitus. Lancet 343: 91-95
13. McMahon M, Gerich J, Rizza R (1988) Effects of glucocorticoids on carbohydrate metabolism. Diabetes Metab Rev 4: 17-30
14. Tappy L, Randin D, Vollenweider P et al. (1994) Mechanisms of dex-induced insulin resistance in healthy humans. J Clin Endocrinol Metab 79: 1063-1069
15. Coderre L, Srivastava AK, Chiasson JL (1992) Effect of hypercorticism on regulation of skeletal muscle glycogen metabolism by epinephrine. Am J Physiol 262: E434-E439
16. Khan A, Östenson CG, Berggren PO, Efendic S (1992) Glucocorticoid increases glucose cycling and inhibits insulin release in pancreatic islets of ob/ob mice. Am J Physiol 263: E663-E666
17. Matsumoto K, Yamasaki H, Akazawa S et al. (1996) Highdose but not low-dose dex impairs glucose tolerance by inducing compensatory failure of pancreatic beta-cells in normal men. J Clin Endocrinol Metab 81: 2621-2626
18. Fajans SS, Conn JW, Arbor A (1954) An approach to the prediction of diabetes mellitus by modification of the glucose tolerance test with cortisone. Diabetes 3: 296-304
19. Conn JW, Fajans SS (1961) The prediabetic state. A concept of dynamic resistance to a genetic diabetogenic influence. Am J Med 31: 839-850
20. Rull JA, Conn JW, Floyd JCJ, Fajans SS (1970) Levels of plasma insulin during cortisone glucose tolerance tests in "nondiabetic" relatives of diabetic patients. Implications of diminished insulin secretory reserve in subclinical diabetes. Diabetes 19: 1-10
21. Bergman RN, Ider YZ, Bowden CR, Cobelli C (1979) Quantitative estimation of Si. Am J Physiol 236: E667-E677
22. Toffolo G, Bergman RN, Finegood DT, Bowden CR, Cobelli C (1980) Quantitative estimation of beta cell sensitivity to glucose in the intact organism: a minimal model of insulin kinetics in the dog. Diabetes 29: 979-990
23. Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI (1985) Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 41: 810-817
24. Hemmila I, Dakubu S, Mukkala V, Siitari H, Lövgren T (1984) Europium as a label in time-resolved immunofluorometric assays. Anal Biochem 137: 335-343
25. Martin IK, Weber KM, Ward GM, Best JD, Boston RC (1990) Application of the SAAM modeling program to minimal model analysis of intravenous glucose tolerance test data. Comput Methods Programs Biomed 33: 193-203
26. Boston RC, Greif PC, Berman M (1981) Conversational SAAM-an interactive program for kinetic analysis of biological systems. Comput Programs Biomed 13: 111-119
27. Kahn SE, Prigeon RL, McCulloch DK et al. (1993) Quantification of the relationship between Si and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42: 1663-1672
28. Weber KM, Martin IK, Best JD, Alford FP, Boston RC (1989) Alternative method for minimal model analysis of intravenous glucose tolerance data. Am J Physiol 256: E524-E535
29. Boston RC, Weber KM (1984) Modeling with SAAM and its advancement in association with mineral metabolism. Math Biosc 72: 191-198
30. Berman M (1963) The formulation and testing of models. Ann N Y Acad Sci 108: 182-194
31. Kahn SE, Prigeon RL, McCulloch DK et al. (1994) The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects. Diabetes 43: 587-592
32. Bergman RN (1989) Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 38: 1512-1527
33. Baron AD, Wallace P, Brechtel G (1987) In vivo regulation of non-insulin-mediated and insulin mediated glucose uptake by cortisol. Diabetes 36: 1230-1237
34. Kautzky Willer A, Thomaseth K, Clodi M et al. (1996) Beta-cell activity and hepatic insulin extraction following dexamethasone administration in healthy subjects. Metabolism 45: 486-491
35. Vaag A, Alford F, Henriksen FL, Christopher M, Beck-Nielsen H (1995) Multiple defects of both hepatic and peripheral intracellular glucose processing contributes to the hyperglycemia of NIDDM. Diabetologia 38: 326-336
36. Christopher MJ, Rantzau C, Ward GM, Alford FP (1995) Insulinopenia and hyperglycemia influence the in vivo partitioning of GE and SI. Am J Physiol 268: E410-E421
37. Beck Nielsen H, Vaag A, Damsbo P et al. (1992) Insulin resistance in skeletal muscles in patients with NIDDM. Diabetes Care 15:418-429
38. Osei K, Cottrell DA, Orabella MM (1991) Insulin sensitivity, glucose effectiveness, and body fat distribution pattern in nondiabetic offspring of patients with NIDDM. Diabetes Care 14: 890-896
39. Gulli G, Ferrannini E, Stern M, Haffner S, DeFronzo RA (1992) The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 41: 1575-1586
40. O'Rahilly SP, Nugent Z, Rudenski AS et al. (1986) Betacell dysfunction, rather than insulin insensitivity, is the-primary defect in familial type 2 diabetes. Lancet 2: 360-364
41. O'Rahilly S, Turner RC, Matthews DR (1988) Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med 318: 1225-1230
42. Johnston C, Ward WK, Beard JC, McKnight B, Porte DJ (1990) Islet function and insulin sensitivity in the non-diabetic offspring of conjugal type 2 diabetic patients. Diabet Med 7: 119-125
43. Haffner SM, Miettinen H, Gaskill SP, Stern MP (1996) Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance. Diabetologia 39: 1201-1208
44. Wajngot A, Giacca A, Grill V, Vranic M, Efendic S (1992) The diabetogenic effects of glucocorticoids are more pronounced in low- than in high-insulin responders. Proc Natl Acad Sci USA 89: 6035-6039
45. Ekstrand AV, Eriksson JG, Gronhagen Riska C, Ahonen PJ, Groop LC (1992) Insulin resistance and insulin deficiency in the pathogenesis of posttransplantation diabetes in man. Transplantation 53: 563-569